MENU
VKTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Viking Therapeutics (VKTX) Ownership - Who owns Viking Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
9920 Pacific Heights Boulevard
Phone
+1 858 704-4660
Employees
27
Web
https://www.vikingtherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.2B
P/E Ratio
N/A
Total Cash
930.44M
Projected Growth
N/A
Total Debt
1.24M
Revenue
N/A
Risk (Beta)
1.13
Dividend Yield
N/A
Total Cash/Share
8.35
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
VKTX
Capitalization
5.2B
P/E Ratio
N/A
Risk (Beta)
1.13
Dividend Yield
N/A
Total Cash
930M
Total Cash/Share
8.35
Total Debt
1.24M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
911M
P/B Ratio
5.71
Cash Flow
N/A
Earnings
-0.94
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
36.47
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-133.66M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-15.02
Shares Held By Institutions
16B
Shares Outstanding - Current
111M
Total Liabilities
26.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
150.940
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company that engages in the development of therapies for metabolic and endocrine disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
9920 Pacific Heights Boulevard
Phone
+1 858 704-4660
Employees
27
Web
https://www.vikingtherapeutics.com